Liproxstatin-1 HCl: Potent Ferroptosis Inhibitor for Rena...
2026-01-22
Liproxstatin-1 HCl, a potent ferroptosis inhibitor from APExBIO, revolutionizes acute renal failure and hepatic injury research by enabling reproducible, selective suppression of iron-dependent regulated cell death. This guide translates cutting-edge mitochondrial and GPX4 regulatory findings into actionable workflows, troubleshooting strategies, and experimental best practices.
Perifosine (KRX-0401): A Synthetic Alkylphospholipid Akt ...
2026-01-21
Perifosine is a synthetic alkylphospholipid and cell-permeable Akt inhibitor validated by robust in vitro and in vivo data. It induces apoptosis via caspase activation and PI3K/Akt/mTOR inhibition, making it a key tool for apoptosis assay, cancer research, and neuroprotection. This article consolidates benchmarks, workflow parameters, and practical limits for researchers.
Trypsin: A Serine Protease Advancing Proteolytic Research
2026-01-21
Trypsin is a serine protease enzyme with high specificity for lysine and arginine residues, supporting advanced research in protease signaling and protein digestion. This article details its biochemical mechanism, experimental benchmarks, and key applications in cell proliferation, wound healing, and viral fusion studies. APExBIO’s Trypsin (SKU: BA5744) offers reproducible results, provided protocol boundaries are respected.
Liproxstatin-1 HCl: Potent Ferroptosis Inhibitor for Acut...
2026-01-20
Liproxstatin-1 HCl stands out as a benchmark ferroptosis inhibitor, enabling precise modulation of iron-dependent regulated cell death in acute renal failure and hepatic injury studies. Its nanomolar potency, proven in vivo efficacy, and workflow flexibility make it indispensable for both mechanistic and translational ferroptosis research.
Eltanexor (KPT-8602): Practical Solutions for Cancer Rese...
2026-01-19
This article provides a scenario-driven, evidence-based analysis of Eltanexor (KPT-8602) (SKU B8335), focusing on its utility and reliability in cell viability, proliferation, and cytotoxicity assays in cancer research. Drawing on published data and real laboratory challenges, it guides biomedical researchers toward reproducible workflows and optimal vendor selection for XPO1 inhibition studies.
470 records 32/32 page Previous First page 上5页 3132